December 14, 2025
July 14, 2026
Immunoglobulin A nephropathy (IgAN) is the most common primary glomerulonephritis globally and an important cause of chronic kidney disease and kidney failure in young adults. As understanding of its complex autoimmune and inflammatory mechanisms deepens, new opportunities are emerging to...
Free CE/CME
December 14, 2025
July 14, 2026
Preliminary results from the recent CATALYST study found hypercortisolism in 24% of patients with type 2 diabetes who are screened for the condition. Given the high prevalence of hidden hypercortisolism among patients with type 2 diabetes, early identification and treatment...
Free CE/CME
December 14, 2025
July 14, 2026
This online, on-demand virtual symposium brings together experts in dry eye disease (DED). In this educational program, these experts share insights into recent neuromodulation opportunities in DED, as well as emerging mechanisms of action, such as targeting TRPM8 thermoreceptors to...
Free CE/CME
December 14, 2025
July 14, 2026
This Expert Illustrations and Commentaries™ symposium features clinical faculty discussing the etiology of hyperphosphatemia in chronic kidney disease (CKD) and its management. The burden of hyperphosphatemia in CKD and the role of the paracellular pathway in phosphate absorption are reviewed,...
Free CE/CME
December 14, 2025
July 14, 2026
The PER Postgame™ is an online, on-demand video program that brings together renowned experts in the treatment of IgA nephropathy (IgAN). In this educational program, these experts review the screening and diagnosis of IgAN utilizing a multidisciplinary approach and delve...
Free CE/CME
December 14, 2025
July 14, 2026
Recent advances in the treatment of presbyopia have focused on pharmacological agents as a novel therapeutic strategy that offers noninvasive, reversible options capable of enhancing depth of focus without altering the natural lens structure. As new and emerging pharmacological therapies...
Free CE/CME
December 14, 2025
July 14, 2026
Modern glaucoma management incorporates a wide variety of therapies, with more options becoming available recently. This educational program offers expert perspectives on individualizing glaucoma therapy with topical medications, selective laser trabeculoplasty, sustained-release drug implants, and micro-invasive glaucoma surgery procedures, providing...
Free CE/CME
December 14, 2025
July 14, 2026
Congenital adrenal hyperplasia (CAH) is a group of rare autosomal recessive disorders that arise from genetic mutation affecting enzymes involved in cortisol synthesis. Depending on the severity of mutations and the loss of functionality of 21-hydroxylase, CAH can take 2...
Free CE/CME
December 14, 2025
July 14, 2026
This online, on-demand virtual symposium brings together renowned experts on Demodex blepharitis. In this educational program, these experts review the diagnosis and management of Demodex blepharitis, including a review of available therapies. This educational activity is an archive of the...
Free CE/CME
December 14, 2025
July 14, 2026
This online, on-demand virtual symposium brings together renowned experts in dry eye disease (DED). In this educational program, these experts use a case-based format to discuss the latest data regarding the management of DED and share their perspectives and best...
Free CE/CME